.jpg)
.png)
On June 3, 2015, the anticipated final results of the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) was published online in the New England Journal of Medicine (NEJM 2015;372:2387-97).
all
Emphasizes the Importance of LDL-Cholesterol Monitoring, LDL Goal Attainment and Shared Decision Making Between Patients and Provider
The National Lipid Association (NLA) was in attendance at the recent American College of Cardiology (ACC) Annual Scientific Session and Expo 2015, March 14-16, in San Diego.